Pfizer is exploring the sale of its hospital drugs unit, as the drugmaker, which has been under pressure from activist ...

Pfizer (PFE) is exploring the sale of its hospital drugs unit ... which include private equity firms and other pharmaceutical companies, the sources said. Published first on TheFly – the ultimate ...

solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction. Virpax Pharmaceuticals, Inc. is a preclinical-stage ...

The selling price is an indication that the FDA’s planned sunsetting of the rare pediatric disease voucher program may be ...

Miami-Dade’s condo sales and dollar volume surged in October, led by a $33 million closing, heralding the start of South ...

Offer could exceed $8 billion plus sales based CVRs ... The primary end point of BioSante Pharmaceuticals' (now ANIP) LibiGel Safety Study is a composite of CV events including death, nonfatal ...

The clinical-stage biopharmaceutical company named Julie Eastland as chief executive officer, president and director. She succeeds Kimberly Blackwell, who will remain as a strategic advisor to the ...

Positive results from completed Phase 2 study of mavorixafor in chronic neutropenia (CN) announced today Pivotal Phase 3 ...

Syndax has entered into a synthetic royalty funding agreement with Royalty Pharma, focused on US net sales of Niktimvo.

The Japanese drugmaker said Thursday that it booked a net profit of 92.0 billion yen, equivalent to $599.6 million, for the three months ended Sept. 30, compared with a net loss of Y48.0 billion in ...

With the rise in global counterfeiting operations, stakeholders need to be aware of their responsibility when it comes to pharmaceutical goods and their legitimacy. Companies can make this task easier ...

Pfizer (PFE) is exploring the sale of its hospital drugs unit, now called Pfizer Hospital, which was formed after Pfizer bought Hospira for ...